New Zealand markets open in 8 hours 19 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.36+0.36 (+0.58%)
As of 09:41AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 78.11B
Enterprise value 98.99B
Trailing P/E 17.39
Forward P/E 9.62
PEG ratio (5-yr expected) 0.53
Price/sales (ttm)2.86
Price/book (mrq)3.92
Enterprise value/revenue 3.60
Enterprise value/EBITDA 15.19

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-11.23%
S&P500 52-week change 3-7.20%
52-week high 374.12
52-week low 357.17
50-day moving average 361.61
200-day moving average 364.29

Share statistics

Avg vol (3-month) 37.09M
Avg vol (10-day) 37.02M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.05%
% held by institutions 182.01%
Shares short (14 Jul 2022) 416.56M
Short ratio (14 Jul 2022) 42.44
Short % of float (14 Jul 2022) 41.32%
Short % of shares outstanding (14 Jul 2022) 41.32%
Shares short (prior month 14 Jun 2022) 415.65M

Dividends & splits

Forward annual dividend rate 42.92
Forward annual dividend yield 44.74%
Trailing annual dividend rate 32.88
Trailing annual dividend yield 34.65%
5-year average dividend yield 43.69
Payout ratio 488.07%
Dividend date 328 Sept 2022
Ex-dividend date 413 Sept 2022
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 15.04%
Operating margin (ttm)40.20%

Management effectiveness

Return on assets (ttm)10.56%
Return on equity (ttm)20.58%

Income statement

Revenue (ttm)27.52B
Revenue per share (ttm)21.92
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)21.78B
Net income avi to common (ttm)4.14B
Diluted EPS (ttm)3.27
Quarterly earnings growth (yoy)-24.80%

Balance sheet

Total cash (mrq)7B
Total cash per share (mrq)5.58
Total debt (mrq)N/A
Total debt/equity (mrq)165.40
Current ratio (mrq)1.49
Book value per share (mrq)16.12

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)10.06B